5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate
|
|
|
- CAS-Nr.
- 162204-20-8
- Englisch Name:
- 5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate
- Synonyma:
- Capecitabine interMediate;(2R,3R,4R,5R)-2-(5-fluoro-2-oxo-4-(((pentyloxy)carbonyl)aMino)pyriMidin-1(2H)-yl)-5-Methyltetrahydrofuran-3,4-diyl diacetate;10G/50G/1KG;5'-Deoxy-5-fL;Capecitabine-7;uoro-N-[(pentyL;Capecitabin iMpurity J;Capecitabine Impurity 2;Capecitabine impurity J;]cytidine 2',3'-diacetate
- CBNumber:
- CB31483335
- Summenformel:
- C19H26FN3O8
- Molgewicht:
- 443.42
- MOL-Datei:
- 162204-20-8.mol
|
5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate Eigenschaften
- Schmelzpunkt:
- 100-102?C
- Dichte
- 1.40±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- L?slichkeit
- soluble in Methanol
- Aggregatzustand
- powder to crystal
- pka
- 5.36±0.40(Predicted)
- Farbe
- White to Almost white
- InChIKey
- WMJHGZFQHPCWQZ-GWBBYGMBSA-N
- SMILES
- C[C@H]1O[C@@H](N2C=C(F)C(NC(OCCCCC)=O)=NC2=O)[C@H](OC(=O)C)[C@@H]1OC(=O)C
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| S-S?tze: |
24/25 |
|
|
| HS Code |
29349990 |
|
|
| Bildanzeige (GHS) |
 
|
| Alarmwort |
Achtung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
| H350 |
Kann Krebs verursachen. |
Karzinogenit?t |
Kategorie 1A |
Achtung |
![GHS hazard pictograms]() src="/GHS08.jpg" width="20" height="20" /> |
|
| H360 |
Kann die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. |
Fertility (Fruchtbarkeit) |
Kategorie 1 |
Achtung |
![GHS hazard pictograms]() src="/GHS08.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
| P264 |
Nach Gebrauch gründlich waschen. |
| P264 |
Nach Gebrauch gründlich waschen. |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P302+P352 |
BEI BERüHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckm??ig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
| P321 |
Besondere Behandlung |
| P332+P313 |
Bei Hautreizung: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen. |
| P362 |
Kontaminierte Kleidung ausziehen und vor erneutem Tragen waschen. |
|
5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White to Off-White Solid
Verwenden
Capecitabine intermediate
Application
5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate, also known as Capecitabine Impurity 2, is an impurity of Capecitabine. Capecitabine is a type of chemotherapy. It is used as a treatment for different types of cancer, including bowel cancer.
5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 287)Lieferanten
162204-20-8()Verwandte Suche:
- 5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetate
- 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate
- Capecitabine Intermediate 1
- [1-(2,3-Di-O-acetyl-5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyriMidinyl]carbaMic Acid Pentyl Ester
- 2',3'-Di-O-acetylcapecitabine
- 10G/50G/1KG
- Cytidine,5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycarboxyl)cytidine
- Capecitabine 2',3'-diacetate
- 2', 3'-Di-O-acetyl-5'-Deoxy-5-Fuluro-N4-(Pentoxycarbonxyl)-Cytidine
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycarboxyl)cytidine
- ICytidine,5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate
- 5'-Deoxy-5-fluoro-N-[(pentyloxy)
- carbonyl]cytidine 2',3'-diacetate
- Capecitabine EP Impurity G
- Capecitabine Impurity 2
- Capecitabine Impurity 7(Capecitabine EP Impurity G)
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-(pentoxycarboxyl)cytidine, 98%
- 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate
- Capecitabin iMpurity J
- Capecitabine impurity J
- 2', 3'-Di-O-acetyl-5'-Deoxy-5-F-N4-(Pentoxycarbonxyl)-Cytidine
- Capecitabine Intermediate-3
- Capecitabine-7
- ]cytidine 2',3'-diacetate
- 5'-Deoxy-5-fL
- uoro-N-[(pentyL
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-(pentyloxycarbonyl)cytidine
- 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 5'
- 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diac...
- Capecitabine interMediate
- (2R,3R,4R,5R)-2-(5-fluoro-2-oxo-4-(((pentyloxy)carbonyl)aMino)pyriMidin-1(2H)-yl)-5-Methyltetrahydrofuran-3,4-diyl diacetate
- dihydro-2-oxo-4-pyrimidinyl]-, pentylester
- 5'- deoxy -5- fluoro -N-[ (pentoxy) carbonyl] cytidine 2',3'- diacetate
- 5'-deoxy-5-fluore-N-[(pentyloxy) carbonyl] cytidine 2',3'-diacetate
- 5'Deoxy5fluoroN[(pentyloxy)carbonyl]cytidine 2',3'diacetate,5' Deoxy 5 fluoro N [(pentyloxy)carbonyl]cytidine 2',3' diacetate
- 5'-deoxi-5-fluoro-N-(pentyloxy)carbonyl cytidine-2',3'- diacetate
- 5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate
- 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycarbonxyl)cytidine
- 5'-deoxy-5-fluore-N-[(pentyloxy) carbonyl] cytidine 2',3'-diacetate
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
- 162204-20-8
- C19H24FN3O10
- Bases & Related Reagents
- Nucleotides
